Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.7 USD | +0.09% | +2.86% | -5.12% |
05-07 | Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs | RE |
05-06 | J&J: encouraging results in prostate cancer | CF |
Sales 2024 * | 88.37B 121B | Sales 2025 * | 90.78B 125B | Capitalization | 358B 491B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 30.27B | Net income 2025 * | 22.98B 31.56B | EV / Sales 2024 * | 3.97 x |
Net cash position 2024 * | 7B 9.61B | Net cash position 2025 * | 21.07B 28.94B | EV / Sales 2025 * | 3.71 x |
P/E ratio 2024 * |
16.5
x | P/E ratio 2025 * |
15.6
x | Employees | 131,900 |
Yield 2024 * |
3.25% | Yield 2025 * |
3.39% | Free-Float | 77.07% |
Latest transcript on Johnson & Johnson
1 day | +0.21% | ||
1 week | +2.86% | ||
Current month | +2.86% | ||
1 month | -2.41% | ||
3 months | -5.86% | ||
6 months | -1.44% | ||
Current year | -5.12% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 0 M€ | +10.86% | - | |
12.91% | 0 M€ | +5.44% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 148.7 | +0.09% | 7,333,545 |
24-05-06 | 148.6 | -0.46% | 5,042,757 |
24-05-03 | 149.3 | -0.43% | 6,532,718 |
24-05-02 | 149.9 | -0.83% | 8,459,796 |
24-05-01 | 151.2 | +4.56% | 14,473,711 |
Delayed Quote Nyse, May 07, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.12% | 358B | |
+33.43% | 690B | |
+26.43% | 546B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B | |
-3.54% | 159B |
- Stock Market
- Equities
- JNJ Stock